Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2010
09/15/2010EP2228448A1 MU-1 member of the cytokine receptor family
09/15/2010EP2228389A2 Antibodies against vascular endothelial growth factor 2
09/15/2010EP2228071A1 Intra-vascular kidney gene therapy with plasmid encoding BMP-7
09/15/2010EP2228069A1 Antagonists of protein kinase c-epsilon (pkcepsilon) and their use for the treatment of aberrant glucose metabolism associated therewith.
09/15/2010EP2227253A1 Vaccine comprising monocyte or immature myeloid cells(imc) which were loaded with the ligand of natural killer t cell and antigen
09/15/2010EP2227236A2 Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
09/15/2010EP1543838B1 Feline infectious peritonitis vaccine
09/15/2010EP1536837B1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
09/15/2010EP1430140B1 N-terminally truncated isoforms of pde3a cyclic phosphodiesterases
09/15/2010EP1303596B1 Morpholino antisense oligomers as enzyme inhibitors for improving pharmacokinetics of a drug
09/15/2010CN101835902A Ultraconserved regions encoding ncrnas
09/15/2010CN101835894A EBI3, DLX5, NPTXl and CDKN3 for target genes of lung cancer therapy and diagnosis
09/15/2010CN101835893A Cancer-related genes, CDCA5, EPHA7, STK31 and WDHD1
09/15/2010CN101831461A Human small RNA-148a expression vector and use thereof
09/15/2010CN101831433A Zebra fish P-selectin gene, encoded protein and application thereof
09/15/2010CN101831427A Oligodeoxyribonudeotide for preventing recurrence of tumor and inhibiting tumor growth as well as application thereof
09/15/2010CN101831411A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
09/15/2010CN101829367A Three-dimensional nano stent of gene delivery system, preparation method and application thereof
09/15/2010CN101829330A Calcium phosphate composite nanoparticle carrying genes as well as preparation method and application thereof
09/15/2010CN101294158B Small numerator interference RNA for inhibiting vascellum endometrial hyperplasia
09/15/2010CN101275135B Antisense oligonucleotide for tissue-specific regulation of POKEMON gene expression and application thereof
09/15/2010CN101066463B Staphylococcus aureau DNA vaccine pcDNA3.1(+)-Minigene and its preparation process
09/14/2010US7795495 utility of beta -synuclein and peptides derived therefrom as anti-amyloidogenic agents ; neurodegenerative diseases such as Alzheimer's and Parkinson's diseases; screening for new anti-amyloidogenic agents
09/14/2010US7795421 siRNA targeting apolipoprotein B (APOB)
09/14/2010US7795420 Short interfering RNA sequences for use in treatment and prevention of diabetes, alzheimer's and cell proliferative disorders
09/14/2010US7795391 Protein showing enhanced expression in cancer cells
09/14/2010US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy
09/14/2010US7795232 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
09/14/2010US7795224 Tumor associated antigen peptides and use of same as anti-tumor vaccines
09/14/2010US7795212 such as viral myocarditis (Coxsackie virus, echovirus, polio virus) or dilated (congestive) cardiomyopathy, by binding ErbB2-ErbB4 receptors; atpase inhibitors
09/14/2010US7795031 Neurodegenerative disease; demyelination diseases; brain disorders; screening stem cells in brain; animal models; Alzheimer's, Parkinson's, Huntington's disease
09/14/2010US7795025 Methods for producing enriched populations of human retinal pigment epithelium cells
09/14/2010US7795017 plasmid constructs useful for the delivery of DNA vaccines; having a transcription cassette capable of directing the expression of a vaccine nucleic acid insert encoding immunogens derived from any pathogen, including fungi, bacteria and viruses
09/14/2010US7794930 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds
09/14/2010US7794929 Detecting a colorectal cancer and/or gastric cancer, detecting selective hybridization of nucleic acid, therapeutic treatment of a cancer, a kit contains oligonucleotide
09/14/2010US7794707 ACE2 activation for treatment of heart, lung and kidney disease and hypertension
09/14/2010US7794704 culturing a multilayer of human embryonic stem cells, for a sufficient time to allow for the appearance of putative cells comprising brown pigment dispersed within their cytoplasm, culturing the putative cells to form a cell monolayer containing cells that are Pax6 negative and bestrophin positive
09/14/2010US7794703 Method for production and delivery of a protein in vivo
09/14/2010US7794702 Expression vector for use as gene transfer tool in treatment of cardiovascular disorders
09/14/2010US7794696 Made from divinyl ethers and diols that may be dimethylol terminated polyamines, polyamides or dendrimers; may be reacted with polynucleotides to form complexes for cell transfection
09/14/2010CA2386231C Membrane translocating peptide drug delivery system
09/14/2010CA2370393C Dna sequence, and recombinant production of a gramineae allergen
09/14/2010CA2343569C Mammalian transforming growth factor beta - 9
09/14/2010CA2261345C Feline polynucleotide vaccine formula
09/14/2010CA2257821C Genes from 20q13 amplicon and their uses
09/10/2010WO2010102058A2 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt 1
09/10/2010WO2010101663A2 Live attenuated influenza virus vaccines comprising microrna response elements
09/10/2010WO2010101249A1 Method for enhancing function of t cell
09/10/2010WO2010101248A1 Cell proliferation inhibitor and method for screening same
09/10/2010WO2010101226A1 Nucleic acid complex and nucleic acid-delivering composition
09/10/2010WO2010100878A1 Vangl1 peptides and vaccines including the same
09/10/2010WO2010100781A1 Composition for nucleic acid delivery
09/10/2010WO2010083338A3 Modulation of pre-mrna using splice modulating oligonucleotides as therapeutic agents in the treatment of disease
09/10/2010WO2010059004A3 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient
09/10/2010WO2010048446A3 Modulation of axon degeneration
09/10/2010CA2754826A1 Live attenuated influenza virus vaccines comprising microrna response elements
09/10/2010CA2754749A1 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
09/10/2010CA2753703A1 Nucleic acid complex and nucleic acid-delivering composition
09/10/2010CA2753681A1 Vangl1 peptides and vaccines including the same
09/09/2010US20100229260 Optimized t-dna transfer and vectors therefor
09/09/2010US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/09/2010US20100227913 Nanoprobes for detection or modification of molecules
09/09/2010US20100227823 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
09/09/2010US20100227407 Aav4 vector and uses thereof
09/09/2010US20100226941 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
09/09/2010US20100226934 Circovirus sequences associated with piglet weight loss disease (pwd)
09/09/2010US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides
09/08/2010EP2225389A1 Sm-protein based secretion engineering
09/08/2010EP2225312A2 Method of preparing a material formed from branched molecules comprising associative groups
09/08/2010EP2224902A1 Cosmetic use of acid ceramidase type proteins
09/08/2010EP1521839B1 Methods of making viral particles having a modified cell binding activity and uses thereof
09/08/2010EP1429797B1 Diagnosis and treatment of malignant neoplasms
09/08/2010EP1377304B1 A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes
09/08/2010EP1328662B1 Flea peritrophin nucleic acid molecules, proteins and uses thereof
09/08/2010EP1196196B1 Conjugate for mediating cell, compartment or membrane-specific transport of active substances
09/08/2010CN1942581B Antibody with osteoclast-related protein as target
09/08/2010CN101827613A Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
09/08/2010CN101827581A Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
09/08/2010CN101824434A Antigen presenting cell, preparation method thereof and application thereof
09/08/2010CN101824430A Double expression plasmid of hepatitis B virus, and construction method and application thereof
09/08/2010CN101824424A DNA vaccine based on B7-2-PE40 exotoxin fusion gene and application thereof
09/08/2010CN101824090A Monoclonal antibody hpam4
09/08/2010CN101822845A Genomic medicine for inhabiting lung cancer transfer and pulmonary metastatic tumor
09/08/2010CN101822844A Tumor targeted molecular chemotherapeutic gene-virus preparation SG500-dNKmut and construction method and applications
09/08/2010CN101822843A Optimization of high-pathogenicity avian influenza virus H5N1-HA gene and recombinant adenovirus vaccine thereof
09/08/2010CN101822842A Reformation of high-pathogenicity avian influenza virus H5N1-HA gene and recombinant adeno-associated virus vaccine thereof
09/08/2010CN101822840A LIGHT-antitumor-antigen antibody for preventing and treating primary and metastatic cancer
09/08/2010CN101822838A Nano-medicament carrier material for target recognition of tumor cell as well as preparation and application thereof
09/08/2010CN101475641B Adenovirus vector avian influenza recombinant vaccine
09/08/2010CN101352365B Positioner for fixing micro organs
09/08/2010CN101219222B Application of PDCD4 recombined expression vector in preparing medicament for treating gonad cancer
09/08/2010CN101168741B Lactococcus lactis food-sate secretion expression carrier and its preparing method and application
09/08/2010CN101058809B Use of humanization modified rat ING4 gene and adenovirus expression vectors in preparing medicine for treating lung cancer
09/07/2010US7790870 nucleic acid molecule encoding a fusion protein comprising four linked polypeptides; suitable for use in gene therapeutical treatment of patients infected with HIV
09/07/2010US7790854 antibody zeta -C2 raised against the sequence set forth in SEQ ID NO:2, which specifically binds to the atypical isoform protein kinase M zeta (PKM zeta ); Alzheimer's disease (AD) and neuroblastoma; using aPKC in diagnosis, drug screening and gene therapy
09/07/2010US7790849 Enhancement of retroviral gene transduction employing polypeptides comprising the fibronectin heparin II binding domain
09/07/2010US7790696 Cationic liposomes containing immune response generating moieties
09/07/2010US7790692 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy
09/07/2010US7790690 Glucose sensitive regulator of insulin transcription
09/07/2010US7790683 Modulation body weights; dietetics; eating disorders; polypeptide having specific amino acid sequence; utilization of D-isoform amino acid substituted leptin-like polypeptides for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 870